doi: 10.1186/s10020-023-00771-x 94 WdowiakNWjtowiczKWdowiak-FilipAPucekWWrbelAWrbelJet al
Their primary indication is the management of type 2 diabetes, where they are used alongside diet and exercise to improve glycaemic control by enhancing insulin secretion, suppressing glucagon, and supporting healthier glucose regulation 3 , 4
The above findings indicate that D-CuP exhibits good biocompatibility, hemocompatibility, anti-inflammatory, antioxidant capabilities, and promotes cell proliferation, migration and angiogenesis
To be clear, Melanotan II: Is not currently approved by the FDA Cannot be legally marketed or sold as a drug, supplement, or cosmetic product Is not used in standard medical practice Is largely unregulated, with no reliable assurance of purity, sterility, or dosing